BlackRock’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.1M | Buy |
1,727,988
+1,711,011
| +10,078% | +$21.9M | ﹤0.01% | 3117 |
|
|
2026
Q1 | $271K | Buy |
16,977
+263
| +2% | +$3.56K | ﹤0.01% | 4686 |
|
|
2025
Q4 | $204K | Buy |
16,714
+16,413
| +5,453% | +$143K | ﹤0.01% | 4718 |
|
|
2025
Q3 | $2.29K | Buy |
301
+1
| +0.3% | +$6 | ﹤0.01% | 5318 |
|
|
2025
Q2 | $1.73K | Hold |
300
| – | – | ﹤0.01% | 5327 |
|
|
2025
Q1 | $1.97K | Hold |
300
| – | – | ﹤0.01% | 5300 |
|
|
2024
Q4 | $1.86K | Hold |
300
| – | – | ﹤0.01% | 5288 |
|
|
2024
Q3 | $1.04K | Hold |
300
| – | – | ﹤0.01% | 5140 |
|
|
2024
Q2 | $904 | Hold |
300
| – | – | ﹤0.01% | 5207 |
|
|
2024
Q1 | $1.27K | Buy |
300
+1
| +0.3% | +$8 | ﹤0.01% | 5197 |
|
|
2023
Q4 | $6.57K | Hold |
299
| – | – | ﹤0.01% | 5180 |
|
|
2023
Q3 | $7.15K | Hold |
299
| – | – | ﹤0.01% | 5222 |
|
|
2023
Q2 | $7.18K | Hold |
299
| – | – | ﹤0.01% | 5282 |
|
|
2023
Q1 | $11.1K | Hold |
299
| – | – | ﹤0.01% | 5310 |
|
|
2022
Q4 | $53.4K | Hold |
299
| – | – | ﹤0.01% | 5213 |
|
|
2022
Q3 | $81K | Hold |
299
| – | – | ﹤0.01% | 5236 |
|
|
2022
Q2 | $144K | Sell |
299
-20
| -6% | -$20K | ﹤0.01% | 5123 |
|
|
2022
Q1 | $413K | Sell |
319
-1
| -0.3% | -$1.11K | ﹤0.01% | 4924 |
|
|
2021
Q4 | $533K | Hold |
320
| – | – | ﹤0.01% | 4853 |
|
|
2021
Q3 | $906K | Hold |
320
| – | – | ﹤0.01% | 4586 |
|
|
2021
Q2 | $1.06M | Sell |
320
-54
| -14% | -$171K | ﹤0.01% | 4496 |
|
|
2021
Q1 | $1.14M | Hold |
374
| – | – | ﹤0.01% | 4463 |
|
|
2020
Q4 | $1.11M | Hold |
374
| – | – | ﹤0.01% | 4188 |
|
|
2020
Q3 | $923K | Hold |
374
| – | – | ﹤0.01% | 4136 |
|
|
2020
Q2 | $543K | Hold |
374
| – | – | ﹤0.01% | 4191 |
|
|
2020
Q1 | $342K | Hold |
374
| – | – | ﹤0.01% | 4132 |
|
|
2019
Q4 | $845K | Hold |
374
| – | – | ﹤0.01% | 4043 |
|
|
2019
Q3 | $719K | Hold |
374
| – | – | ﹤0.01% | 4082 |
|
|
2019
Q2 | $827K | Hold |
374
| – | – | ﹤0.01% | 4063 |
|
|
2019
Q1 | $1.21M | Buy |
+374
| New | +$853K | ﹤0.01% | 3853 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4916 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4859 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4851 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4784 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4684 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4746 |
|
|
2017
Q2 | – | Sell |
-2
| Closed | -$33.3K | – | 4739 |
|
|
2017
Q1 | $39K | Buy |
+2
| New | +$72.7K | ﹤0.01% | 4509 |
|
Other funds holding TENX
PAM
AA
DT
KPF
BlackRock's TENX Position: Q2 2026 in Review
BlackRock increased its Tenax Therapeutics (TENX) stake by 10,078% in Q2 2026, buying an estimated $21.9M and bringing the position to 1,727,988 shares worth $25.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3117.
BlackRock first reported a position in TENX in Q1 2017 and has held it in 31 quarters since. 23 funds tracked by Wall St. Rank hold TENX as of Q2 2026.
- BlackRock held 1,727,988 shares of Tenax Therapeutics worth $25.1M as of Q2 2026.
- BlackRock bought 1,711,011 Tenax Therapeutics shares in Q2 2026, an estimated $21.9M.
- Tenax Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3117 holding.
- BlackRock first reported a position in Tenax Therapeutics in Q1 2017 and has held it in 31 quarters since.
- 23 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.